Table 1.
Patient characteristics
| Chains | Number of Patients |
Age of dispensing |
Female | White | |
|---|---|---|---|---|---|
| (Mean±SD) | |||||
|
Chain1† |
424 |
63.9 |
± 12.0 |
50.70% |
83.20% |
|
Chain2 |
489 |
61.2 |
± 13.0 |
43.90% |
87.50% |
|
Chain3 |
693 |
66.4 |
± 10.4 |
51.50% |
81.70% |
|
Chain4† |
727 |
60.7 |
± 13.1 |
45.20% |
91.20% |
|
Chain5† |
810 |
53.5 |
± 12.3 |
52.30% |
84.20% |
|
Chain6‡ |
966 |
57.3 |
± 12.6 |
45.60% |
83.60% |
|
Chain7 |
1,708 |
60.8 |
± 11.0 |
40.10% |
89.60% |
|
Chain8 |
2,892 |
60.8 |
± 10.2 |
40.80% |
91.80% |
|
Chain9 |
3,461 |
64.0 |
± 11.0 |
43.10% |
87.80% |
|
Chain10† |
3,932 |
59.1 |
± 12.8 |
51.00% |
87.70% |
|
Chain11† |
5,623 |
57.6 |
± 12.3 |
50.80% |
82.40% |
|
Chain12 |
7,971 |
58.2 |
± 12.8 |
51.70% |
75.10% |
|
Chain13 |
9,882 |
66.6 |
± 10.6 |
43.10% |
85.10% |
|
Chain14† |
16,788 |
59.1 |
± 12.9 |
49.00% |
79.00% |
| MEPS | 13.7million | 60.7 | ± 12.8 | 44.2% | 66.8% |
† Chain with a LCPP.
‡ Chain with LCPP for Chlorpropamide only.